CO32 | Major surgery in patients with severe hemophilia A without inhibitors receiving prophylaxis with fitusiran
Background and Aims: Fitusiran is an RNA interference therapy that lowers antithrombin (AT) levels, thereby restoring hemostatic balance in patients with hemophilia A or B, regardless of inhibitor status. However, clinical experience with perioperative management of major surgery in patients receiv...
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
PAGEPress Publications
2025-07-01
|
| Series: | Bleeding, Thrombosis and Vascular Biology |
| Subjects: | |
| Online Access: | https://www.btvb.org/btvb/article/view/239 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|